Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  acetaminophen
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Phase IV Randomized Pilot Study of Oxycodone Hydrochloride Versus Standard Three-Step Analgesic Therapy in Patients With Cancer-Related Pain. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CRUK-ON/2003/1772, EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937
T3AI-Pain After Breast Surgery
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: CDHA008, NCT00299039
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI
Protocol IDs: POG-7831, MDAR-319
Phase II Chemotherapy with DCF Alternating with IFN-alpha A in Patients with Hairy Cell Leukemia (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8509, NCI-85-C-193, NCI-T85-0282N, T85-0282
Phase II Chemotherapy with BLEO plus Chemopotentiation with Trifluoperazine in Patients with Malignant Brain Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor:
Protocol IDs: YALE-HIC-3839, NCI-V86-0093
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSTI571A2107, NCT00428909
Start Over